Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03171480 · ClinicalTrials.gov registry record · Phase 4

Use of Nitrous Oxide Donor for Labor Induction in Women With PreEclampsia

A Phase 4 study, sponsored by Ohio State University.

Completed
Registry status
Phase 4
Development phase
176
Enrollment target

NCT03171480: Completed Phase 4 study, sponsored by Ohio State University.

NCT03171480 is a Phase 4 study that has completed, run by Ohio State University. The registered enrollment target is 176 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03171480, a Phase 4 study, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
Phase 4
Development phase
176 participants
Enrollment target

Study Summary

A randomized controlled trial (RCT) of nitric-oxide donor (NOD) isosorbide mononitrate (IMN) versus placebo as an adjuvant to misoprostol/ intra-cervical Foley bulb for induction of labor to decrease rate of cesarean deliveries in pregnancies complicated by preeclampsia (≥24/0 weeks' gestation)

Primary Outcome

Rate of cesarean section for those enrolled in study

Interventions

  • DRUG Placebo
  • DRUG Monoket Pill

Trial Details

FieldValue
Enrollment Target 176 participants
Start Date 2017-10-30
Est. Completion 2020-07-01
Phase Phase 4
Ohio State University

552 total trials

What the finished NCT03171480 record still lists

NCT03171480 is an interventional study that assigns participants to a tested intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (66% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT03171480 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03171480 about?

NCT03171480 is a clinical study titled "Use of Nitrous Oxide Donor for Labor Induction in Women With PreEclampsia". A randomized controlled trial (RCT) of nitric-oxide donor (NOD) isosorbide mononitrate (IMN) versus placebo as an adjuvant to misoprostol/ intra-cervical Foley bulb for induction of labor to decrease rate of cesarean deliveries in pregnancies complicated by preeclampsia (≥24/0 weeks' gestation)

What is the current status of trial NCT03171480?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 176 participants. The study started on 2017-10-30. Estimated completion is 2020-07-01.

What interventions are being tested in trial NCT03171480?

The interventions under investigation include: Placebo (DRUG), Monoket Pill (DRUG).

Who is sponsoring clinical trial NCT03171480?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03171480's enrollment target sits among peer trials

176 477th of 2000 higher than 1,523 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03304821 · 176 participants · Phase 2

    Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease

  • NCT03447938 · 176 participants · NA

    The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial

  • NCT03824145 · 176 participants · NA

    Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer

  • NCT04177914 · 176 participants · Phase 3

    HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03171480, the US trial registry maintained by the National Library of Medicine. NCT03171480 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.